Three Senior Executives of Henan Topfond Pharmaceutical Under Investigation

On November 22, China General Technology (Group) Holding released three official announcements through its official channels, all concerning the investigation of senior executives at Henan Topfond Pharmaceutical Co., Ltd. (SHA: 600253). The details are as follows:

1. Investigation of Deputy General Manager Zhang Mingchun
   According to the disciplinary inspection and supervision team of China General Technology Group and the supervisory committee of Xuchang City, Henan Province: Zhang Mingchun, Deputy General Manager of Henan Topfond Pharmaceutical Co., Ltd, is suspected of serious disciplinary and legal violations and is currently under disciplinary review and supervisory investigation by the China General Technology Group’s disciplinary inspection and supervision team and the supervisory committee of Changge City, Xuchang, Henan Province.
2. Investigation of Former Deputy General Manager of the Preparation Division Zhang Junqing
   The disciplinary inspection and supervision team of China General Technology Group and the supervisory committee of Xuchang City, Henan Province report that Zhang Junqing, former Deputy General Manager of the Preparation Division at Henan Topfond Pharmaceutical Co., Ltd, is suspected of serious disciplinary and legal violations and is currently under disciplinary review and supervisory investigation by the same authorities.
3. Investigation of General Manager Assistant Zhang Erhua
   Zhang Erhua, General Manager Assistant at Henan Topfond Pharmaceutical Co., Ltd, is also suspected of serious disciplinary and legal violations and is currently under disciplinary review and supervisory investigation by the China General Technology Group’s disciplinary inspection and supervision team and the supervisory committee of Changge City, Xuchang, Henan Province.

Background on Henan Topfond Pharmaceutical
Established in 1969, Henan Topfond Pharmaceutical is a large-scale comprehensive pharmaceutical enterprise specializing in the production and sales of finished preparations, chemical synthetic raw materials, and biological fermentation raw materials, as well as pharmaceutical operations. It integrates science, industry, and trade and was listed on the Shanghai Stock Exchange in December 2000. In August 2008, Henan Topfond Pharmaceutical joined China General Technology Group. In July 2013, it successfully merged with China Meheco Group Co., Ltd (SHA: 600056) through a share exchange, formally coming under its management.-Fineline Info & Tech